Related references
Note: Only part of the references are listed.Serum C-reactive Protein (CRP) Levels in Cancer Patients are Linked with Tumor Burden and are Reduced by Anti-hypertensive Medication
Michael I. Koukourakis et al.
INFLAMMATION (2009)
Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness
Ahlame Saidi et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
A Compartment Model of VEGF Distribution in Humans in the Presence of Soluble VEGF Receptor-1 Acting as a Ligand Trap
Florence T. H. Wu et al.
PLOS ONE (2009)
α2-6-linked sialic acids on N-glycans modulate carcinoma differentiation in vivo
Maria Hedlund et al.
CANCER RESEARCH (2008)
Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS)
S. S. Soedamah-Muthu et al.
DIABETOLOGIA (2008)
New molecular targets in angiogenic vessels of glioblastoma tumours
Joshua C. Anderson et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer
Yu-Ting Chang et al.
PANCREAS (2008)
Atorvastatin neutralizes the up-regulation of thrombospondin-1 induced by thrombin in human umbilical vein endothelial cells
Vicenta Martinez-Sales et al.
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH (2007)
Associations of circulating C-reactive protein and interleukin-6 with survival in women with and without cancer:: Findings from the British Women's Heart and Health Study
Katriina Heikkila et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Venous thromboembolism and survival in patients with high-grade glioma
Ralph Simanek et al.
NEURO-ONCOLOGY (2007)
Interleukin-6 gene amplification and shortened survival in glioblastoma patients
A. Tchirkov et al.
BRITISH JOURNAL OF CANCER (2007)
Soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) is decreased in lung cancer patients showing progression: A pilot study
A. Yilmaztepe et al.
CANCER INVESTIGATION (2007)
Inflammation, a key event in cancer development
HT Lu et al.
MOLECULAR CANCER RESEARCH (2006)
Endogenous inhibitors of angiogenesis in malignant gliomas: Nature's antiangiogenic therapy
TA Rege et al.
NEURO-ONCOLOGY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer
F Tas et al.
MEDICAL ONCOLOGY (2005)
Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia
S Ahmad et al.
CIRCULATION RESEARCH (2004)
Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer
M Toi et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Vascular endothelial growth factor (VEGF) is elevated in brain tumor cysts and correlates with tumor progression
G Stockhammer et al.
ACTA NEUROPATHOLOGICA (2000)
Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells
M Tenan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
